0001587221-18-000029.txt : 20180601 0001587221-18-000029.hdr.sgml : 20180601 20180601191229 ACCESSION NUMBER: 0001587221-18-000029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180531 FILED AS OF DATE: 20180601 DATE AS OF CHANGE: 20180601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WILSON TROY EDWARD CENTRAL INDEX KEY: 0001589597 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36570 FILM NUMBER: 18876588 MAIL ADDRESS: STREET 1: C/O PUMA BIOTECHNOLOGY INC. STREET 2: 10880 WILSHIRE BOULEVARD, SUITE 2150 CITY: LOS ANGELES STATE: CA ZIP: 90024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zosano Pharma Corp CENTRAL INDEX KEY: 0001587221 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 454488360 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 34790 ARDENTECH COURT CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 510-745-1200 MAIL ADDRESS: STREET 1: 34790 ARDENTECH COURT CITY: FREMONT STATE: CA ZIP: 94555 FORMER COMPANY: FORMER CONFORMED NAME: ZP Holdings Inc DATE OF NAME CHANGE: 20130919 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2018-05-31 0001587221 Zosano Pharma Corp ZSAN 0001589597 WILSON TROY EDWARD C/O ZOSANO PHARMA CORPORATION 34790 ARDENTECH COURT FREMONT CA 94555 1 0 0 0 Stock Option (right to buy) 4.24 2018-05-31 4 A 0 25000 0 A 2028-04-16 Common Stock 25000 25000 D The option grant was approved by the compensation committee of the Company's board of directors on April 16, 2018, subject to stockholder approval of an amendment to the stock option plan under which the option was granted. The Company's stockholders approved the plan amendment on May 31, 2018. The shares underlying the stock option vest in equal monthly installments over a four-year period, beginning on May 16, 2018, so that all shares shall have vested on April 16, 2022. /s/ Jeffrey L. Quillen, attorney-in-fact 2018-06-01